Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients.


Eleven panic disorder patients who panicked in response to exogenous cholecystokinin tetrapeptide (CCK-4) were rechallenged after chronic treatment with imipramine. In the rechallenge the patients displayed a marked reduction in the number and intensity of panic symptoms, duration of symptoms, frequency of panic attacks, and cardiovascular responsiveness… (More)


  • Presentations referencing similar topics